Grupo Financiero Galicia SA (GGAL3):企業の財務・戦略的SWOT分析

◆英語タイトル:Grupo Financiero Galicia SA (GGAL3) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0266
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アルゼンチン
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Grupo Financiero Galicia SA (GGAL3) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Grupo Financiero Galicia S.A. (GFG) is a financial services holding company that offers banking, insurance, and investment solutions through its subsidiaries. It product portfolio includes checking and savings accounts; time deposits; credit and debit cards; personal and mortgage loans; deposit certificates; safety lockers; warrants; and insurance coverage for life, property and casualty, and retirement. It also provides treasury management, leasing, factoring, online banking and capital market and investment banking services. GFG is headquartered in Buenos Aires, Argentina.

Grupo Financiero Galicia SA Key Recent Developments

Feb 08,2018: GFGA’S reports fourth quarter results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Grupo Financiero Galicia SA – Key Facts
Grupo Financiero Galicia SA – Key Employees
Grupo Financiero Galicia SA – Key Employee Biographies
Grupo Financiero Galicia SA – Major Products and Services
Grupo Financiero Galicia SA – History
Grupo Financiero Galicia SA – Company Statement
Grupo Financiero Galicia SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Grupo Financiero Galicia SA – Business Description
Business Segment: Banking
Overview
Performance
Key Stats
Business Segment: Insurance
Overview
Performance
Key Stats
Business Segment: Other Businesses
Overview
Performance
Key Stats
Business Segment: Regional Cards
Overview
Performance
Key Stats
Grupo Financiero Galicia SA – SWOT Analysis
SWOT Analysis – Overview
Grupo Financiero Galicia SA – Strengths
Grupo Financiero Galicia SA – Weaknesses
Grupo Financiero Galicia SA – Opportunities
Grupo Financiero Galicia SA – Threats
Grupo Financiero Galicia SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Grupo Financiero Galicia SA, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 08, 2018: GFGA’S reports fourth quarter results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Grupo Financiero Galicia SA, Key Facts
Grupo Financiero Galicia SA, Key Employees
Grupo Financiero Galicia SA, Key Employee Biographies
Grupo Financiero Galicia SA, Major Products and Services
Grupo Financiero Galicia SA, History
Grupo Financiero Galicia SA, Subsidiaries
Grupo Financiero Galicia SA, Key Competitors
Grupo Financiero Galicia SA, Ratios based on current share price
Grupo Financiero Galicia SA, Annual Ratios
Grupo Financiero Galicia SA, Annual Ratios (Cont...1)
Grupo Financiero Galicia SA, Interim Ratios
Grupo Financiero Galicia SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Grupo Financiero Galicia SA, Performance Chart (2014 - 2018)
Grupo Financiero Galicia SA, Ratio Charts

★海外企業調査レポート[Grupo Financiero Galicia SA (GGAL3):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vedanta Resources Plc:企業の戦略・SWOT・財務分析
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PENTAX Medical Co:医療機器:M&Aディール及び事業提携情報
    Summary Pentax Medical Co (Pentax Medical), a subsidiary of Pentax of America Inc, is a medical device company that offers endoscopic products and services. The company offers products such as colonoscopes, sigmoidscopes, echoendoscopes, small bowel enteroscope, duodenoscopes, choledochoscope, advan …
  • Four Seasons Hotels Ltd:企業の戦略・SWOT・財務情報
    Four Seasons Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Four Seasons Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Qiagen Aarhus AS:企業の戦略的SWOT分析
    Qiagen Aarhus AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務分析
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mega International Commercial Bank Co Ltd:企業の戦略・SWOT・財務情報
    Mega International Commercial Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega International Commercial Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • SBM Offshore NV (SBMO):企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • JD Sports Fashion Plc:企業のM&A・事業提携・投資動向
    JD Sports Fashion Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JD Sports Fashion Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • LifeLabs Inc-医療機器分野:企業M&A・提携分析
    Summary LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, me …
  • Hobby Lobby Stores Inc:企業の戦略・SWOT・財務分析
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Onex Corporation:企業の戦略・SWOT・財務分析
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Seres Therapeutics Inc (MCRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Grupo TMM, S.A.B.:企業の戦略・SWOT・財務情報
    Grupo TMM, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo TMM, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析
    PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • John B. Sanfilippo & Son, Inc.:企業の戦略・SWOT・財務情報
    John B. Sanfilippo & Son, Inc. - Strategy, SWOT and Corporate Finance Report Summary John B. Sanfilippo & Son, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Copan Italia SpA:医療機器:M&Aディール及び事業提携情報
    Summary Copan Italia SpA (Copan Italia) is a medical equipment provider that offers lab consumables and diagnostic products. The company’s products include clinical products, lab automation products, and genetics, forensics, and lab consumable products, among others. Its lab automation products allo …
  • Muhibbah Engineering (M) Bhd:企業の戦略・SWOT・財務情報
    Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report Summary Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chronos Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Chronos Therapeutics Ltd (Chronos) is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆